Be Biopharma - Crunchbase Company Profile & Funding

Q: Who invested in Be Biopharma?

Be Biopharma has 8 investors including Takeda Ventures And RA Capital Management.

Q: When was the last funding round for Be Biopharma?

Be Biopharma closed its last funding round on obfuscated from a Series C round.

Q: How much funding has Be Biopharma raised to date?

Be Biopharma has raised obfuscated.

Overview

Be Biopharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Be Biopharma

CB Rank

11556

Be Biopharma develops engineered B cell medicines for serious genetic diseases.

Founded

obfuscation

Private

Series C

Cambridge, Massachusetts, United States

51-100

www.be.bio

Biopharma

Biotechnology

Pharmaceutical

Funding Rounds

Series C

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Series B

OBF

obfuscation

Key People

Lea Hachigian: Co-founder
Aleks Radovic-Moreno: Co-Founder, President & Board Member
Past Role: Vor Biopharma, Co-Founder

Details

Legal Name

Be Biopharma, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Aleks Radovic-Moreno, David Rawlings, David Steinberg, Lea Hachigian, Richard James

About the Company

Be Biopharma pioneers engineered B cell medicines aimed at improving treatments for conditions like Hemophilia B and cancer. Their innovative approach utilizes precision genome editing to create durable and effective cell therapies.

Contact Email

info@bebiopharma.com

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Insight

See this Growth Insight

Be Biopharma is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

BE-101

An engineered B cell medicine designed to provide continuous expression of Factor IX for treating Hemophilia B.

BE-102

A B cell medicine candidate engineered to secrete tissue nonspecific alkaline phosphatase for treating Hypophosphatasia.

Research & Development

Be Biopharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Be Biopharma	8	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Be Biopharma	8	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Be Biopharma	8	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Be Biopharma	8	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Be Biopharma	8	obfuscated obfuscation	—	Series C

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Be Biopharma	8	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Be Biopharma	8	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Be Biopharma	8	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Be Biopharma	8	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Be Biopharma	8	obfuscated obfuscation	—	Series C

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Takeda Ventures	—	Series C - Be Biopharma	—
Takeda Ventures	—	Series C - Be Biopharma	—
Takeda Ventures	—	Series C - Be Biopharma	—
Takeda Ventures	—	Series C - Be Biopharma	—
Takeda Ventures	—	Series C - Be Biopharma	—